TATVA

Tatva Chintan Pharma Chem Share PriceTatva Chintan Pharma Chem

₹1651.00
-3.35 (-0.2%)
As on 05 June, 2023 | 02:01 BSE: 543321 NSE: TATVA

Tatva Chintan Pharma Chem Performance

Day Range

  • Low
  • High
1651.00

52 Week Range

  • Low
  • High
1651.00
  • Open Price
  • Previous Close
  • Volume

Start SIP in Tatva Chintan Pharma Chem

Start SIP

Tatva Chintan Pharma Chem Share Price

  • Over 1 Month -3.1%
  • Over 3 Month -12.79%
  • Over 6 Month -26.7%
  • Over 1 Year -31.13%

Tatva Chintan Pharma Chem Key Statistics

P/E Ratio 80.5
PEG Ratio -1.5
Market Cap Cr 3,660
Price to Book Ratio 7.1
EPS 19.8
Dividend 0.1
Relative Strength Index 48.11
Money Flow Index 59.25
MACD Signal -14.42
Average True Range 41.62

Tatva Chintan Pharma Chem Investment Rating

  • Master Rating:
  • Tatva Chintan Pharma Chem has an operating revenue of Rs. 423.61 Cr. on a trailing 12-month basis. An annual revenue de-growth of -3% needs improvement, Pre-tax margin of 11% is healthy, ROE of 8% is fair but needs improvement. The company has a reasonable debt to equity of 1%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its 200DMA and close to its 50DMA. It needs to take out the 200DMA levels and stay above it to make any further meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 58 which is a POOR score indicating inconsistency in earnings, a RS Rating of 10 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at C which is evident from recent supply seen, Group Rank of 63 indicates it belongs to a poor industry group of Chemicals-Basic and a Master Score of D is close to being the worst. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Tatva Chintan Pharma Chem Financials
IndicatorMar 2023Dec 2022Sep 2022Jun 2022Mar 2022
Oper Rev Qtr Cr 1191148486102
Operating Expenses Qtr Cr 10497757380
Operating Profit Qtr Cr 151791322
Depreciation Qtr Cr 32222
Interest Qtr Cr 32111
Tax Qtr Cr -93231
Net Profit Qtr Cr 16115919

Tatva Chintan Pharma Chem Technicals

EMA & SMA

Current Price
₹1651.00
-3.35 (-0.2%)
  • Bullish Moving Average
  • ___
  • 4
  • Bearish Moving Average
  • ___
  • 12
  • 20 Day
  • ₹1653.29
  • 50 Day
  • ₹1702.16
  • 100 Day
  • ₹1821.05
  • 200 Day
  • ₹1988.8
  • 20 Day
  • ₹1642.91
  • 50 Day
  • ₹1666.05
  • 100 Day
  • ₹1832.35
  • 200 Day
  • ₹2103.77

Tatva Chintan Pharma Chem Resistance and Support

PIVOT
₹1658.77
Resistance
First Resistance ₹1666.49
Second Resistance ₹1678.62
Third Resistance ₹1686.34
RSI 48.11
MFI 59.25
MACD Single Line -14.42
MACD -9.57
Support
First Resistance ₹1646.64
Second Resistance ₹1638.92
Third Resistance ₹1626.79

Tatva Chintan Pharma Chem Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 8,688 557,422 64.16
Week 13,225 934,875 70.69
1 Month 25,050 1,283,585 51.24
6 Month 13,894 917,705 66.05

Tatva Chintan Pharma Chem Result Highlights

Tatva Chintan Pharma Chem Synopsis

NSE-Chemicals-Basic

Tatva Chintan Pharm is involved in the business activities of Manufacture of organic and inorganic chemical compounds. Company’s Total Operating Revenue is Rs. 403.04 Cr. and Equity Capital is Rs. 22.17 Cr. for the Year ended 31/03/2023. Tatva Chintan Pharma Chem Ltd. is a Public Limited Listed company incorporated on 12/06/1996 and has its registered office in the State of Gujarat, India. Company’s Corporate Identification Number(CIN) is L24232GJ1996PLC029894 and registration number is 029894.
Market Cap 3,659
Sales 403
Shares in Float 0.47
No of funds 31
Yield 0.12
Book Value 7.25
U/D Vol ratio 0.8
LTDebt / Equity 1
Alpha -0.16
Beta 0.82

Tatva Chintan Pharma Chem

Owner NameMar-23Dec-22Sep-22Jun-22
Promoters 79.17%79.17%79.17%79.17%
Mutual Funds 10.98%11.12%10.8%10.34%
Insurance Companies 0.53%0.2%0.17%0.22%
Foreign Portfolio Investors 3.54%3.74%3.59%3.53%
Individual Investors 5.09%5.01%5.49%6.03%
Others 0.69%0.76%0.78%0.71%

Tatva Chintan Pharma Chem Management

Name Designation
Mr. Chintan Nitinkumar Shah Chairman & Managing Director
Mr. Ajaykumar Mansukhlal Patel Whole Time Director
Mr. Shekhar Rasiklal Somani Whole Time Director
Dr. Manher Chimanlal Desai Independent Director
Mr. Subhash Ambubhai Patel Independent Director
Dr. Avani Rajesh Umatt Independent Director

Tatva Chintan Pharma Chem Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Tatva Chintan Pharma Chem Corporate Action

Date Purpose Remarks
2023-05-05 Audited Results & Final Dividend
2023-01-24 Quarterly Results
2022-11-04 Quarterly Results
2022-07-25 Quarterly Results
2022-04-25 Audited Results & Final Dividend
Date Purpose Remarks
2022-09-09 FINAL Rs.2.00 per share(20%)Final Dividend

Tatva Chintan Pharma Chem MF Shareholding

Name Amount(cr)
Nippon India Small Cap Fund - Growth 26294
Nippon India Tax Saver (ELSS) Fund - Growth 11451
Axis Flexi Cap Fund Regular Growth 10731
SBI Magnum Midcap Fund Regular Growth 9370
Mirae Asset Hybrid Equity Fund -Regular Plan-Growth 7188

Tatva Chintan Pharma Chem FAQs

What is Share Price of Tatva Chintan Pharma Chem ?

Tatva Chintan Pharma Chem share price is ₹1651 As on 05 June, 2023 | 01:47

What is the Market Cap of Tatva Chintan Pharma Chem ?

The Market Cap of Tatva Chintan Pharma Chem is ₹3659.5 Cr As on 05 June, 2023 | 01:47

What is the P/E ratio of Tatva Chintan Pharma Chem ?

The P/E ratio of Tatva Chintan Pharma Chem is 80.5 As on 05 June, 2023 | 01:47

What is the PB ratio of Tatva Chintan Pharma Chem ?

The PB ratio of Tatva Chintan Pharma Chem is 7.1 As on 05 June, 2023 | 01:47

Q2FY23

Start Investing Now!

Open Free Demat Account in 5 mins

Enter Valid Mobile Number